MDK08445
| Code | Size | Price |
|---|
| TAR-T27992-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
MDK08445 is an important intermediate or precursor for the synthesis of Cefiderocol, a potent siderophore cephalosporin antibiotic.
CAS:
1225208-44-5
Formula:
C29H33ClN2O5
Molecular Weight:
525.04
Purity:
0.98
SMILES:
COc1ccc(COc2ccc(C(=O)NCCN3CCCC3)c(Cl)c2OCc2ccc(OC)cc2)cc1
References
1. Preparation of intermediate of cephalosporin derivatives. Fukuda, Mayu; Watanabe, Takeaki; Kurita, Takanori; Yokota, Yutaka; Takeo, Masatoshi; Noguchi, Kouichi. PCT Int. Appl. (2016), WO 2016035847 A1 20160310, Language: Japanese, Database: CAPLUS
2. Pharmaceutical preparation comprising cephalosporin having catechol groups with improved stability, and manufacture thereof. Kawasaki, Hidenori; Kojima, Natsuko; Fujihira, Atsushi; Takahashi, Kanako; Matsubara, Fumihiko; Matsuoka, Nao. PCT Int. Appl. (2016), WO 2016035846 A1 20160310,
3. Preparation of 2-substituted cephem compounds as antibacterial agents. Yamawaki, Kenji; Yokoo, Katsuki; Sato, Jun; Kusano, Hiroki; Aoki, Toshiaki; Liao, Xiangmin; Pearson, Neil David; Pendrak, Israil; Thalgi, Reema. Jpn. Kokai Tokkyo Koho (2015), JP 2015221788 A 20151210,
4. Preparation of 2-substituted cephem compounds as antibacterial agents. Liao, Xiangmin; Pearson, Neil David; Pendrak, Israil; Thalgi, Reema; Yamawaki, Kenji; Yokoo, Katsuki; Sato, Jun; Kusano, Hiroki; Aoki, Toshiaki. PCT Int. Appl. (2014), WO 2014068388 A1 20140508,